)
IMCD (IMCD) investor relations material
IMCD Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Gross profit reached EUR 927 million, up 5% year-over-year on a constant currency basis, despite macroeconomic and tariff challenges.
Operating EBITA was EUR 394 million, a 1% increase on a constant currency basis, with growth driven by organic performance and acquisitions.
Six acquisitions in 2025 are expected to add EUR 340 million in revenue and 185 employees on a full-year basis, expanding presence in key markets.
Free cash flow for the period was EUR 284 million, with cash earnings per share at EUR 4.16.
The business model demonstrated resilience, with intensified efforts on cost-effectiveness, commercial excellence, and digital initiatives.
Financial highlights
Revenue for the first nine months of 2025 was EUR 3,676 million, up 3% year-over-year (6% FX adjusted).
Gross profit margin was 25.2%, slightly down from 25.4% in the prior year, mainly due to acquisitions and product mix.
Operating EBITA margin was 10.7%, down from 11.2% year-over-year.
Net result declined to EUR 180 million, an 11% decrease year-over-year, mainly due to lower EBITA and higher finance costs.
Free cash flow was EUR 284 million, down from EUR 299 million in the same period of 2024.
Outlook and guidance
Management remains confident in the long-term outlook, expecting year-end cash conversion ratio in the high 80% to low 90% range.
No significant improvement in order visibility; market remains volatile with just-in-time deliveries and minimal forecasting.
Expectation for pharma market softness to be short-term, with normalization anticipated in Q1.
Focus remains on earnings growth through service optimization and market position strengthening.
- TimeTickerHeadlineOpen
- FRU
Q3 2025 saw 10% production growth, 37% higher net income, and expanded credit facilities. - DCH
Q3 2025 saw flat sales, higher margins, and strong cash flow as the Dowlais deal advances. - 6103
Strong sales growth and robust orders drive higher profits; outlook and dividend unchanged. - BERG
Q3 EBITA up 12% and margins improved, with strong acquisition activity and new divisional structure. - ALIF
Profitability and margins improved, debt reduced, and outlook for 2026 is strong. - 4475
Sales and ARR grew strongly, but higher costs and expenses pressured net profit and margins. - DEVYANI
Revenue increased but net losses persisted; major acquisitions and amalgamation approved. - DNB
Q4 2025 saw strong growth and high returns, but annual profit fell due to higher costs and impairments. - DNB
Q4 2025 profit NOK 11.6bn, 16.6% ROE, NOK 18 dividend, and strong CET1 at 17.9%. - PARADEEP
Revenue and profit surged on higher volumes, MCFL merger, and expansion, with regulatory changes noted.
Next IMCD earnings date
Next IMCD earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage